| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M601518200 |
| P698 | PubMed publication ID | 16803905 |
| P50 | author | Julie A. Leary | Q6307994 |
| P2093 | author name string | Tracy M Handel | |
| Yonghao Yu | |||
| Susan E Crown | |||
| Matthew D Sweeney | |||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein heterodimerization activity | Q14762999 |
| P304 | page(s) | 25438-25446 | |
| P577 | publication date | 2006-06-27 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding | |
| P478 | volume | 281 |
| Q58692523 | A Dynamic Overview of Antimicrobial Peptides and Their Complexes |
| Q50999277 | A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes. |
| Q41789851 | An Ion Mobility-Mass Spectrometry Investigation of Monocyte Chemoattractant Protein-1. |
| Q38338415 | Analysis of Glycosaminoglycans Using Mass Spectrometry |
| Q41839089 | CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations |
| Q39975348 | Chapter 2. Homo- and hetero-oligomerization of chemokines |
| Q41863804 | Chapter 3. Lymphotactin structural dynamics. |
| Q46176996 | Chapter 4. Interactions of chemokines with glycosaminoglycans |
| Q33885243 | Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. |
| Q33624473 | Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions |
| Q35528569 | Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies |
| Q27693462 | Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking. |
| Q37608845 | Chemokine oligomerization in cell signaling and migration |
| Q47154563 | Chemokines from a Structural Perspective |
| Q37198842 | Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican |
| Q43489161 | Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice |
| Q48224823 | Electrostatic Forces as Dominant Interactions Between Proteins and Polyanions: an ESI MS Study of Fibroblast Growth Factor Binding to Heparin Oligomers. |
| Q34691652 | Emerging mass spectrometry-based approaches to probe protein-receptor interactions: focus on overcoming physiological barriers |
| Q38819497 | Exploiting agonist biased signaling of chemokines to target cancer. |
| Q28262855 | Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis |
| Q42366882 | Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System |
| Q38311148 | Immune mechanisms in acetaminophen-induced acute liver failure |
| Q31153582 | Immune-related chemotactic factors were found in acute coronary syndromes by bioinformatics |
| Q39150505 | In vivo immune interactions of multipotent stromal cells underlie their long-lasting pain-relieving effect |
| Q42064793 | Ion mobility mass spectrometry coupled with rapid protein threading predictor structure prediction and collision-induced dissociation for probing chemokine conformation and stability |
| Q55342457 | Local Delivery Is Critical for Monocyte Chemotactic Protein-1 Mediated Site-Specific Murine Aneurysm Healing. |
| Q89588789 | Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin |
| Q37481208 | Monocyte chemoattractant protein-1 (MCP-1): an overview |
| Q92538377 | More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis |
| Q33652172 | Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine |
| Q36403522 | NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery |
| Q37684330 | Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. |
| Q38815332 | New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. |
| Q28818194 | Probing Functional Heteromeric Chemokine Protein-Protein Interactions through Conformation-Assisted Oxime Ligation |
| Q41573564 | Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration |
| Q33649788 | Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™ |
| Q38022773 | Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. |
| Q43588267 | Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes |
| Q91973506 | Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation |
| Q81077941 | The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides |
| Q37684793 | Therapeutic targeting of chemokine interactions in atherosclerosis |
| Q36090029 | Touch of chemokines |
| Q34044686 | Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site |
Search more.